Case Study / Wellness Technology
How We Drove $7 Million in Hyperbaric Chamber Sales: The HBOT Case Study
$7 million in hyperbaric chamber sales placed across med spas, surgery centers, hospitals, and longevity clinics for one HBOT manufacturer. This case study covers the four buyer segments we identified, the channel mix that produced the sales, the FDA-cleared-indication marketing approach, and the dealer enablement layer that scaled the run.
The starting point: a hyperbaric chamber manufacturer with no US marketing function
The brand came to Raging Agency as an international hyperbaric chamber manufacturer with strong engineering credentials, multiple FDA 510(k) clearances, and an underdeveloped US market presence. The product line covered mild HBOT consumer chambers, medical HBOT clinical chambers for FDA-cleared indications, and high-end multi-place chambers for hospital and surgery center installations. The US channel was running through a small dealer network and one trade show per year, producing inconsistent pipeline and limited brand recognition outside the existing buyer base. We took over US marketing with a mandate to build the brand, scale the dealer channel, and produce direct B2B pipeline through digital channels.
The four buyer segments for hyperbaric chambers
The first move was segmentation. We identified four distinct buyer segments with different price tolerances, different sales cycles, and different compliance frames. First, med spas adding HBOT as a longevity and recovery cross-sell (typical purchase $35,000 to $80,000 single-occupant chamber, 60 to 120 day sales cycle, prioritizing payback math on the chair). Second, surgery centers using HBOT for wound care, post-surgical recovery, and FDA-cleared indications ($100,000 to $250,000 chamber, 120 to 240 day sales cycle, prioritizing UHMS accreditation support and reimbursement workflow). Third, hospitals running clinical HBOT programs ($200,000 to $400,000 multi-place chamber, 180 to 360 day sales cycle, prioritizing capital approval pathway and clinical training). Fourth, longevity clinics and high-net-worth installations (variable pricing, 90 to 180 day cycle, prioritizing custom install and concierge service).
The FDA-cleared-indication marketing approach
The marketing approach that worked across all four segments leaned hard into the 13 FDA-cleared indications for hyperbaric oxygen therapy: carbon monoxide poisoning, decompression sickness, gas gangrene, acute traumatic ischemia, crush injury, diabetic foot ulcers, radiation tissue damage, chronic refractory osteomyelitis, compromised skin grafts and flaps, severe anemia, intracranial abscess, thermal burns, and sudden hearing loss. The cleared indications served two purposes: they provided a defensible marketing claim set for clinical buyers, and they anchored the brand in regulatory legitimacy that wellness-only positioning could not provide.
For med spa and longevity buyers, the marketing approach shifted to the FDA General Wellness Policy frame. Off-label HBOT use (longevity, recovery, cognitive performance, athletic recovery) cannot be marketed as medical treatment, so the creative used General Wellness language and routed to landing pages where the buyer was educated on the cleared-indication clinical credibility plus the wellness-positioning use cases. See our wellness ad compliance guide for the full framework.
Channel mix: digital, trade show, dealer, and referral
The channel mix that produced the $7M run combined four channels. Digital paid media (Meta and Google) drove roughly 30% of pipeline, concentrated on the med spa and longevity clinic segments where the buyer is researching online. Trade show capture drove roughly 25% of pipeline, concentrated on surgery center and hospital segments (UHMS annual scientific meeting, A4M annual meeting, AmSpa annual conference). Dealer and distributor channel drove roughly 30% of pipeline, scaled significantly through dealer enablement investment. Referral and word of mouth from existing clinical installations drove roughly 15% of pipeline, accelerating in months 6 to 18 as the install base reached critical mass.
Dealer enablement: the channel that scaled the run
Dealer enablement was the single most leveraged channel across the $7M run. The starting state: limited dealer network, no dealer-specific marketing assets, no demo equipment lending program, no co-branded landing pages. The investment: dedicated dealer success manager hired into the manufacturer, co-branded landing pages built for each major dealer, dealer-specific creative library produced, ROI calculators built for clinic and surgery center buyers, financing partner integration (equipment lease partners covering 60 to 84 month financing), demo equipment lending program, and a quarterly dealer training program. The dealer channel scaled from roughly 15% of pipeline to roughly 30% of pipeline over the engagement.
Unit economics and the path to $7M
Unit economics stabilized across the first 6 months of the engagement and scaled across months 6 to 24. Average deal size ran $85,000 for med spa segment, $180,000 for surgery center segment, $310,000 for hospital segment, $125,000 for longevity clinic segment. Cost per acquired customer ran 8 to 15% of first-purchase revenue depending on segment. The $7M total run was produced across 38 chamber sales over 24 months, with the run rate accelerating significantly in months 12 to 24 as referral and dealer channels compounded. Total marketing investment across the run produced a 5.8x return on ad spend by month 24.
Five lessons for any HBOT or wellness device manufacturer
Five lessons transfer to any hyperbaric chamber or high-ticket wellness device manufacturer selling B2B into clinical and longevity channels. First, segment the buyer types before building the funnel. Second, lean into FDA-cleared indications as marketing assets, not constraints. Third, invest in dealer enablement early -- the channel scales harder than direct digital for B2B clinical buyers. Fourth, build a clinical credibility content engine in the first 6 months. Fifth, treat compliance as table stakes -- the FDA enforcement history in HBOT means one warning letter can damage the brand for years.
What we would do differently today: invest in AI search visibility (AEO and GEO) from day one, integrate HSA/FSA eligibility through Truemed earlier for prosumer and longevity buyer segments, and invest in podcast partnerships with longevity and biohacking personalities for the longevity clinic and prosumer buyer segments. The $7M playbook still works -- the channel mix has moved. See the full manufacturer context on our wellness tech maker marketing page.
Frequently asked questions about HBOT manufacturer marketing
How long does it take to scale a hyperbaric chamber manufacturer?
Hyperbaric chamber manufacturer scaling typically requires 18 to 36 months of channel investment to reach meaningful unit volume in the US clinical and longevity segments. The first 6 months are foundation building (clinical credibility content, dealer enablement infrastructure, compliance audit, funnel architecture). Months 6 to 12 are channel scaling and dealer expansion. Months 12 to 24 are compounding leverage as referral, dealer, and direct channels mature. The $7M run referenced here took 24 months from engagement start, with significant acceleration in months 12 to 24.
Can you advertise hyperbaric oxygen therapy on Facebook and Google?
Yes, for FDA-cleared indications and for wellness positioning under the FDA General Wellness Policy. The constraints: no marketing claims outside the 13 cleared indications without explicit General Wellness Policy framing, no off-label disease treatment claims (autism, cancer, Lyme, Alzheimer's specifically), and no before-and-after testimonials referencing unapproved uses. Compliant HBOT creative leads with clinical credibility (UHMS accreditation, FDA clearances, cleared-indication outcomes), founder POV from medical staff, or General Wellness positioning for longevity and recovery use cases.
What is dealer enablement for hyperbaric chamber manufacturers?
Dealer enablement is the set of marketing and sales support assets that lets dealers effectively sell, demo, and service hyperbaric chambers without manufacturer involvement on every deal. The components: co-branded landing pages for each dealer, dealer-specific creative libraries, ROI calculators for clinic and surgery center buyers, demo equipment lending program, financing partner integration, clinical training and certification program, and a dedicated dealer success manager. Strong dealer enablement scales channel revenue 2 to 4x what unsupported dealer relationships produce.
What is the typical sales cycle for a hospital or surgery center HBOT installation?
Hospital and surgery center HBOT installations typically run 180 to 360 days from first contact to signed PO. The cycle covers clinical need assessment, capital budget approval, facility planning (space requirements, electrical, oxygen supply), procurement review, vendor evaluation, clinical training planning, UHMS accreditation pathway review where applicable, and final contract execution.
How do you handle compliance for off-label HBOT use cases like longevity?
Off-label HBOT use cases (longevity, recovery, cognitive performance, athletic recovery) are marketed under the FDA General Wellness Policy frame without making medical treatment claims. The compliant approach: General Wellness language ("supports recovery," "supports general wellness," "designed to assist with longevity protocols"), explicit off-label disclaimer where the use case is discussed, and no before-and-after testimonials referencing FDA enforcement zones.
Want a hyperbaric chamber or wellness device marketing engine built on the lessons of a $7M run?
Book a 20-minute Strategy Call.
We will look at your current funnel, channel mix, and dealer infrastructure, and quote a plan if it fits.